Home » Diagnostics » Drug Discovery & Development

Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

BioAge Labs Raises $10.9M, Partners with Estonian Genome Center With Aim to Develop Anti-Aging Drugs

Premium

The firm now intends to set up an internal laboratory to experiment with different compounds, while building out its team.

Cowen Initiates Coverage of Horizon Discovery at Outperform

The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic.

Thermo Fisher Completes $7.2B Patheon Acquisition

Thermo Fisher has acquired the contract development and manufacturing organization for $35 per share in cash.

GWAS Data Analysis Generates List of Candidate Drugs for Psychiatric Conditions

Researchers from Hong Kong imputed transcriptomes from GWAS data and compared them to drug-induced gene expression profiles.

FDA Okays WIN Consortium Trial to Test Three-Drug NSCLC Combo; Validate SIMS Algorithm

Premium

The SPRING trial is exploring a three-drug strategy, starting with Ibrance, Inlyta, and Bavencio, and will validate a biomarker algorithm for predicting responders.


Aug 10, 2017

Alexion, Sema4 Partner to Improve Diagnosis of Rare Diseases

Jul 13, 2017

Kura Oncology Taps Foundation Medicine to ID Patients for Cancer Drug Trial

Jul 10, 2017

CRISPR Therapeutics, Neon Therapeutics Enter Research Collaboration

Jun 27, 2017

Sema4, GNS Healthcare Collaborate on Machine Learning for Therapy Discovery

Jun 27, 2017

Basket Study Supported Keytruda Pan-Cancer Indication But Challenges Remain

Premium
Jun 12, 2017

Genome Canada, Pharma Partners Commit C$33M to Structural Genomics Consortium

Jun 06, 2017

New Precision Oncology Options Emerge at ASCO in First-Line EGFR-Mutated, ALK-Positive Lung Cancer

Premium
Jun 04, 2017

ASCO Expands TAPUR Sites; Inks Collaborations to Investigate Precision Oncology Globally

May 31, 2017

ImiDomics, Celgene Partner on Immune-Mediated Inflammatory Disease Research

May 25, 2017

Targeting ANGPTL3 Could Lead to Development of Heart Disease Therapies

May 15, 2017

Thermo Fisher Buying Pharma Contract Development and Manufacturing Firm Patheon for $7.2B

Apr 21, 2017

Aevi Genomic Medicine IDs Best Responder Subset For ADHD Drug

Premium
Apr 20, 2017

Single-Cell RNA-Seq Reveals New Dendritic Cell, Monocyte Subtypes

Apr 18, 2017

Pfizer, HitGen Partner to Develop DNA-Encoded Libraries

Apr 11, 2017

Startup 1Cellbio Inks Single-Cell Sequencing Collaboration With UCB

Apr 03, 2017

HER2 Mutant Basket Trial Confirms Drug Response Depends on Mutation, Cancer Type

Mar 30, 2017

Foundation Medicine, Bristol-Myers Squibb Collaborate on Tumor Profiling

Mar 30, 2017

Tango Therapeutics Launches With $55M Series A Financing

Mar 28, 2017

Aldevron Licenses Tech for Development of Multiple Myeloma Treatments

Mar 23, 2017

GlaxoSmithKline, Regeneron Partner to Sequence Entire UK Biobank

More articles

The Scan

Synthetic Genomics Sued for Gender Discrimination

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Football Team's DNA Day Postponed

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

To Interfere

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

This Week in Cell

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.

What's Popular?

In Drug Discovery & Development

  1. BioAge Labs Raises $10.9M, Partners with Estonian Genome Center With Aim to Develop Anti-Aging Drugs

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.